Creative Biolabs is Offering High-throughput Sequencing Services for Cancer Worldwide

Creative Biolabs provides a full set of cancer research relevant sequencing services, aiming to assist medical researchers with solving biological issues and understanding the molecular mechanisms of many diseases including human cancers.

Shirley, United States - August 30, 2019 /MarketersMedia/

Creative Biolabs has been dedicated to improving the human cancer diagnosis and precision medicine from a biomedical perspective, offering sequencing solutions with experienced scientists and advanced technology platform—SuPrecision™ Platform, on which the services can be operable include but are not confined to Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, Whole Transcriptome Sequencing (WTS), Immune Repertoire Sequencing (Rep-seq), Bioinformatics Analysis, etc.

Whole Genome Sequencing (WGS)
As the core propeller for various medical researches, whole genome sequencing constitutes a crucial part in the cancer research projects and complex genetic malfunction. The service is capable of undertaking germline variant detection, somatic variant detection, whole genome re-sequencing, de novo genome assembly, copy number variation, structural variant discovery, and so on. The whole workflow of WGS starts from experimental design, and then followed by library preparation, sequencing, and finally to genomics analysis to ensure 99.99% accurate result.
Applications: capturing large/small variants; identifying unknown genes; obtaining high-standard de novo assemblies; identifying the change of genetic predisposition; providing information for specialized cancer treatment plans.

Whole Exome Sequencing (WES)
Creative Biolabs owns extensive experience accumulated in Whole Exome Sequencing program associated with corresponding WES Bioinformatic Analysis, in the field of next-generation sequencing (NGS). Equipped with the state of the art SuPrecision™ Platform, the WES for cancer enables experimental design, library preparation & exome enrichment, sequencing, and variant calling & downstream analysis, guaranteeing various variants identification, comprehensive coding region coverage, and quick turnaround.
Applications: tumor mutational burden (TMB) analysis; variants analysis; structural variants detection; copy-number variation analysis; tumor-specific neoantigen identification, etc.

Whole Transcriptome Sequencing (WTS)
The whole transcriptome sequencing services cover more than mRNA sequencing (miRNA/CircRNA/LncRNA/Exosome RNA sequencing are also available.), which are offered in the aim of improving the messenger RNA transcriptome sequencing (mRNA-Seq) to a powerful support for researching disease transcription. The WTS solutions hold the competence of investigating all possible RNAs from known to novel, detecting new and rare transcripts/transcript variants, enabling long read lengths for low expressed full-length transcripts, and allowing the study of isoforms, splice variants and fusion transcripts. The corresponding transcriptome analysis stands as a supplement to meet every customer’s requirements as it should be.
Applications: library preparation; high-throughput sequencing; bioinformatics analysis.

“We hope to optimize your research process on personalized medicine with our NGS services,” said the head of Creative Biolabs. Services provided for cancer research, aside from the above-introduced ones, also compose comprehensive bioinformatic analysis solutions. Having been working on a large number of NGS projects for years, valuable data and experience accumulate simultaneously, which will consummate global customers’ projects efficiently. For details regarding the next-generation sequencing services, please visit https://www.creative-biolabs.com/suprecision/.

About the Company
Creative Biolabs, since the establishment in 2004, has been regarded as the leading service provider in the area of next-generation sequencing (NGS). Holding the extensive exploration experience, the scientists built a comprehensive SuPrecision™ Platform to provide precise and high throughput sequencing services especially for cancer.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Address: 45-1 Ramsey Road
Phone: 1-631-619-7922
Website: https://www.creative-biolabs.com/suprecision/

Source URL: https://marketersmedia.com/creative-biolabs-is-offering-high-throughput-sequencing-services-for-cancer-worldwide/88913845

Source: MarketersMedia

Release ID: 88913845

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.